CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

A new nasal whooping cough vaccine showed an ability to prevent both infection and transmission of the disease in mice. Current vaccines offer treatment but fail to halt transmission of the bacteria ...

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology IndustriesFAYETTEVILLE, Ark., Nov.

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

After decades of disappointment, efforts to create jabs that can stimulate the immune system to fight cancer are showing ...

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the ...

Vaccine adjuvants are microbial components comprising of chemicals or mammalian proteins that are added to a vaccine to increase the efficiency of th ...

Current pertussis vaccines are widely used and effective at preventing whooping cough, caused by the Bordetella pertussis ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology company focused on developing and commercializing innovative protein-based vaccines to combat serious infectious diseases, ...